Future Oncology, Volume 20, Issue 3 (2024)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Future Oncology, Volume 20, Issue 3 (2024)

See all volumes and issues
Volume 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Commentary

Editorial
Prognostication for Surgically Treated Papillary Renal Cell Carcinoma: Which Model is the Optimal Choice?
Michele Maffezzoli & Sebastiano Buti
Pages: 107-111
Published online: 07 Feb 2024
AbstractforPrognostication for Surgically Treated Papillary Renal Cell Carcinoma: Which Model is the Optimal Choice? | Full Text | References | PDF (1.4 MB) | EPUB
  • 44 Views
  • 0 CrossRef citations
  • 0Altmetric

Plain Language Summary of Publication

Plain Language Summary of Publication
Long-Term Benefit of Sotorasib in Patients With KRAS G12C–Mutated Non–Small-Cell Lung Cancer: Plain Language Summary
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, Gerald S Falchook, Antoine Italiano, Jürgen Wolf, Adrian G Sacher, Toshiaki Takahashi, Suresh S Ramalingam, Christophe Dooms, Dong-Wan Kim, Alfredo Addeo, Jayesh Desai, Martin Schuler, Pascale Tomasini, David S Hong, Piro Lito, Qui Tran, Simon Jones, Abraham Anderson, Antreas Hindoyan, Wendy Snyder, Ferdinandos Skoulidis & Bob T Li
Pages: 113-120
Published online: 27 Nov 2023
First Page PreviewforLong-Term Benefit of Sotorasib in Patients With KRAS G12C–Mutated Non–Small-Cell Lung Cancer: Plain Language Summary | PDF (1.4 MB)
  • 2591 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Clinical Trial Protocol

Review Article
NeoSCORE II: Three Vs Four Cycles of Neoadjuvant Sintilimab + Chemotherapy for Squamous Non-Small-Cell Lung Cancer
Xinyi Zhang, Miner Shao, Jie Yao, Lufeng Zhao, Lili Li, Mengyao Chen, Yixin Zhang, Huiying Liu, Zexin Chen, Baizhou Li, Zuqun Wu, Junqiang Fan & Fuming Qiu
Pages: 121-129
Published online: 14 Feb 2024
AbstractforNeoSCORE II: Three Vs Four Cycles of Neoadjuvant Sintilimab + Chemotherapy for Squamous Non-Small-Cell Lung Cancer | Full Text | References | PDF (1.7 MB) | EPUB
  • 154 Views
  • 0 CrossRef citations
  • 0Altmetric

Short Communication

Brief Report
In-Class Transition from Bortezomib-Based Therapy to IRd is an Effective Approach in Newly Diagnosed Multiple Myeloma
Robert M Rifkin, Caitlin L Costello, Ruemu E Birhiray, Suman Kambhampati, Joshua Richter, Rafat Abonour, Hans C Lee, Michael Stokes, Kaili Ren, Dawn Marie Stull, Dasha Cherepanov, Kimberly Bogard, Stephen J Noga & Saulius Girnius
Pages: 131-143
Published online: 09 Oct 2023
AbstractforIn-Class Transition from Bortezomib-Based Therapy to IRd is an Effective Approach in Newly Diagnosed Multiple Myeloma | Full Text | References | PDF (2.5 MB) | EPUB | Supplemental
  • 1065 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Achieving White Blood Cell Equity: Are the Safety Profiles of Biosimilar and Reference Pegfilgrastims Comparable?
Arturo Loaiza-Bonilla & Ray D Page
Pages: 145-158
Published online: 23 Aug 2023
AbstractforAchieving White Blood Cell Equity: Are the Safety Profiles of Biosimilar and Reference Pegfilgrastims Comparable? | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 791 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Corrigendum

Correction
Corrigendum
Pages: 159-161
Published online: 07 Feb 2024
First Page PreviewforCorrigendum | Full Text | PDF (1.4 MB) | EPUB
  • 185 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer
Anwaar Saeed et al.
Method | Published online: 23 Jul 2024
Gastric cancer in pregnancy: a review
Hongming Liu et al.
Review Article | Published online: 23 Jul 2024
A novel prognostic index for extranodal natural killer/T-cell lymphoma in the era of pegaspargase/L-asparaginase
Ziyuan Shen et al.
Article | Published online: 23 Jul 2024
An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial
Juanjuan Dai et al.
Method | Published online: 21 Jul 2024
View all latest articles